|
π
|
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
39 auth.
R. Coombes,
K. Page,
R. Salari,
R. Hastings,
A. Armstrong,
Samreen I. Ahmed,
Simak Ali,
S. Cleator,
L. Kenny,
J. Stebbing,
Mark Rutherford,
H. Sethi,
A. Boydell,
R. Swenerton,
D. Fernandez-Garcia,
...
Kelly L. T. Gleason,
K. Goddard,
D. Guttery,
Z. Assaf,
Hsin-Ta Wu,
Prashanthi Natarajan,
David A J Moore,
L. Primrose,
S. Dashner,
Antony S. Tin,
M. BalcioΔlu,
R. Srinivasan,
S. Shchegrova,
A. Olson,
D. Hafez,
P. Billings,
A. Aleshin,
F. Rehman,
B. Toghill,
A. Hills,
M. Louie,
C. J. Lin,
B. Zimmermann,
Jaqueline A. Shaw
|
8 |
2019 |
8
π
|
|
π
|
Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids
13 auth.
K. Page,
D. Guttery,
Nathalie Zahra,
L. Primrose,
Shona R. Elshaw,
J. Pringle,
K. Blighe,
Stephanie D. Marchese,
A. Hills,
L. Woodley,
...
J. Stebbing,
R. C. Coombes,
Jacqueline A Shaw
|
7 |
2013 |
7
π
|
|
π
|
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts
14 auth.
J. Shaw,
D. Guttery,
A. Hills,
D. Fernandez-Garcia,
K. Page,
Brenda M. Rosales,
K. Goddard,
R. Hastings,
Jinli Luo,
Olivia Ogle,
...
L. Woodley,
Simak Ali,
J. Stebbing,
C. Coombes
|
7 |
2016 |
7
π
|
|
π
|
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer.
13 auth.
D. Guttery,
K. Page,
A. Hills,
L. Woodley,
Stephanie D. Marchese,
B. Rghebi,
R. Hastings,
Jinli Luo,
J. Pringle,
J. Stebbing,
...
R. C. Coombes,
Simak Ali,
Jacqueline A Shaw
|
7 |
2015 |
7
π
|
|
π
|
Mutations in the Ξ³-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa).
9 auth.
A. Pink,
M. Simpson,
N. Desai,
D. Dafou,
A. Hills,
P. Mortimer,
...
Catherine H. Smith,
R. Trembath,
J. Barker
|
7 |
2012 |
7
π
|
|
π
|
Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.
12 auth.
D. Costea,
A. Hills,
A. H. Osman,
J. Thurlow,
G. Kalna,
Xiaohong Huang,
...
C. PeΓ±a Murillo,
H. Parajuli,
S. Suliman,
K. Kulasekara,
A. Johannessen,
M. Partridge
|
7 |
2013 |
7
π
|
|
π
|
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
15 auth.
D. Fernandez-Garcia,
A. Hills,
K. Page,
R. Hastings,
B. Toghill,
K. Goddard,
C. Ion,
Olivia Ogle,
A. Boydell,
Kelly L. T. Gleason,
...
Mark Rutherford,
A. Lim,
D. Guttery,
R. Coombes,
Jacqueline A Shaw
|
6 |
2019 |
6
π
|
|
π
|
Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer.
13 auth.
Karen Page,
D. Guttery,
D. Fernandez-Garcia,
A. Hills,
R. Hastings,
Jinli Luo,
K. Goddard,
Vedia Shahin,
L. Woodley-Barker,
Brenda M. Rosales,
...
R. Coombes,
J. Stebbing,
J. Shaw
|
6 |
2017 |
6
π
|
|
π
|
p53 Mutations in Deep Tissues Are More Strongly Associated with Recurrence than Mutation-Positive Mucosal Margins
10 auth.
Xiaohong Huang,
S. Pateromichelakis,
A. Hills,
M. Sherriff,
A. Lyons,
J. Langdon,
...
E. Odell,
P. Morgan,
John Harrison,
M. Partridge
|
5 |
2007 |
5
π
|
|
π¬
|
Tissue engineering of oral dysplasia
K. Gaballah,
D. Costea,
A. Hills,
S. Gollin,
Paul R. Harrison,
M. Partridge
|
4 |
2008 |
4
π¬
|
